ML Model Uses Methylation Patterns to Identify Tissue of Origin
Objective:
To develop a machine learning model that predicts tissue of origin in cancers of unknown primary using a focused set of DNA methylation patterns.
Key Findings:
- The model achieved an area under the curve of 0.998 and classification accuracy of 0.954 in internal validation.
- In the TCGA held-out test cohort, the model maintained a high area under the curve of 0.998 and accuracy of 0.947.
- Errors in classification reflected biological similarities rather than model failures.
Interpretation:
The model effectively captures tumor biology through DNA methylation patterns, offering a promising tool for identifying tissue of origin in cancers of unknown primary.
Limitations:
- The study primarily focused on a limited set of cancer types.
- Further validation is needed in cohorts of patients with true cancers of unknown primary.
Conclusion:
The developed classifier has the potential to improve site-directed therapy decision-making for patients with cancers of unknown primary, complementing existing genomic profiling methods.
ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.